Zdrowie i gospodarka · 16/06/2022
FDA Clears THEO-DUR Extended-Release Tablets for Continued Sale
The FDA has determined that the 100mg and 300mg versions of THEO-DUR extended-release tablets were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications for the product.